Skip to main content
Clinical Trials/PER-049-00
PER-049-00
Completed
未知

OPEN, CONTROLLED EXTENSION STUDY IN CHRONIC ASTHMA TO COMPARE THE EFFECT OF MONTELUKAST WITH PLACEBO IN PATIENTS FROM 2 TO 5 YEARS OF AGE

MERCK SHARP & DOHME PERU S.R.L.,0 sites0 target enrollmentAugust 15, 2000

Overview

Phase
未知
Intervention
Not specified
Conditions
-J458 Mixed asthma
Sponsor
MERCK SHARP & DOHME PERU S.R.L.,
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2000
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
MERCK SHARP & DOHME PERU S.R.L.,

Eligibility Criteria

Inclusion Criteria

  • The patient arrived satisfactorily until Visit 24 of Protocol 072\-11\.
  • The parent / legal guardian accepts the patient´s participation in the study as indicated by the signature of the parent / legal guardian on the consent form. The patient and the parent / guardian are willing to comply with the procedures and both the patient and the parent / guardian can make the scheduled clinical visits.

Exclusion Criteria

  • The consent of the parent or guardian can not be obtained.
  • The patient is hospitalized.
  • The patient suffered a serious or adverse clinically important experience that is still present at Visit 24 of Protocol 072\-11\.
  • The patient experiences significant changes from the clinical point of view in his general medical condition since he enrolled in Protocol 072\-11\.

Outcomes

Primary Outcomes

Not specified

Similar Trials